Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials

References

• UNAIDS World AIDS Day Report 2011 (2011). Joint United Nations Programme on HIV/AIDS (UNAIDS). Available: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/JC2216_WorldAIDSday_report_2011_en.pdf
   Google Scholar
• Center for Epidemiological Studies on HIV/AIDS and STIs in Catalonia (CEEISCAT). (2010). Integrated System of Epidemiological surveillance of HIV/AIDS /STIs in Catalonia (SIVES 2010): Biannual Report: Generalitat de Catalunya, Health Department: http://www.ceescat.org/Index_Ing.htm.
   Google Scholar
• Brown-Peterside P, Rivera E, Lucy D, Slaughter I, Ren L, Chiasson MA, et al. Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE. Am J Public Health 2001; 91:1377 - 9; http://dx.doi.org/10.2105/AJPH.91.9.1377; PMID: 11527761
   PubMed Web of Science ®Google Scholar
• Tarimo EA, Thorson A, Kohi TW, Bakari M, Sandstrom E, Mhalu F, et al. A qualitative evaluation of volunteers’ experiences in a phase I/II HIV vaccine trial in Tanzania. BMC Infect Dis 2011; 11:283; http://dx.doi.org/10.1186/1471-2334-11-283; PMID: 22023776
   PubMed Web of Science ®Google Scholar
• Bansal GP, Malaspina A, Flores J. Future paths for HIV vaccine research: Exploiting results from recent clinical trials and current scientific advances. Curr Opin Mol Ther 2010; 12:39 - 46; PMID: 20140815
   PubMed Web of Science ®Google Scholar
• Joseph J, Etcheverry F, Alcami J, Gatell JM. A safe, effective and affordable HIV vaccine--an urgent global need. AIDS Rev 2005; 7:131 - 8; PMID: 16302460
   PubMed Web of Science ®Google Scholar
• Schechter M, do Lago RF, de Melo MF, Sheppard HW, Guimarães NC, Moreira RI, et al, Projeto Praço Onze Study Group. Identification of a high-risk heterosexual population for HIV prevention trials in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2000; 24:175 - 7; PMID: 10935694
   PubMed Web of Science ®Google Scholar
• Dhalla S, Poole G. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. AIDS Care 2011; 23:1430 - 47; http://dx.doi.org/10.1080/09540121.2011.555750; PMID: 21722022
   PubMed Web of Science ®Google Scholar
• Dhalla S, Poole G. Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. Vaccine 2011; 29:5850 - 9; http://dx.doi.org/10.1016/j.vaccine.2011.06.055; PMID: 21740947
   PubMed Web of Science ®Google Scholar
• Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, et al. Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol 2001; 153:619 - 27; http://dx.doi.org/10.1093/aje/153.7.619; PMID: 11282787
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Sirisopana N, Charonwatanachokchai A, Julvanichpong W, Siraprapasiri T, Palanuvej T, et al. Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:488 - 94; http://dx.doi.org/10.1097/00042560-199904150-00012; PMID: 10225232
   PubMedGoogle Scholar
• Colfax G, Buchbinder S, Vamshidar G, Celum C, McKirnan D, Neidig J, et al. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005; 39:359 - 64; http://dx.doi.org/10.1097/01.qai.0000152039.88422.ec; PMID: 15980699
   PubMed Web of Science ®Google Scholar
• Halpern SD, Metzger DS, Berlin JA, Ubel PA. Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acquir Immune Defic Syndr 2001; 27:281 - 8; PMID: 11464149
   PubMed Web of Science ®Google Scholar
• Kiwanuka N, Robb M, Kigozi G, Birx D, Philips J, Wabwire-Mangen F, et al. Knowledge about vaccines and willingness to participate in preventive HIV vaccine trials: a population-based study, Rakai, Uganda. J Acquir Immune Defic Syndr 2004; 36:721 - 5; http://dx.doi.org/10.1097/00126334-200406010-00009; PMID: 15167291
   PubMed Web of Science ®Google Scholar
• Smit J, Middelkoop K, Myer L, Seedat S, Wood R, Stein DJ, et al. Sexual risk factors associated with volunteering for HIV vaccine research in South Africa. AIDS Care 2006; 18:569 - 73; http://dx.doi.org/10.1080/09540120500274976; PMID: 16831784
   PubMed Web of Science ®Google Scholar
• Robinson KA, Dennison CR, Wayman DM, Pronovost PJ, Needham DM. Systematic review identifies number of strategies important for retaining study participants. 2007; 60:757 - 65
   Google Scholar
• Froelicher ES, Miller NH, Buzaitis A, Pfenninger P, Misuraco A, Jordan S, et al. The Enhancing Recovery in Coronary Heart Disease Trial (ENRICHD): strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation. J Cardiopulm Rehabil 2003; 23:269 - 80; http://dx.doi.org/10.1097/00008483-200307000-00004; PMID: 12894001
   PubMedGoogle Scholar
• Parra-Medina D, D’antonio A, Smith SM, Levin S, Kirkner G, Mayer-Davis E, POWER study. Successful recruitment and retention strategies for a randomized weight management trial for people with diabetes living in rural, medically underserved counties of South Carolina: the POWER study. J Am Diet Assoc 2004; 104:70 - 5; http://dx.doi.org/10.1016/j.jada.2003.10.014; PMID: 14702587
   PubMed Web of Science ®Google Scholar
• Bailey JM, Bieniasz ME, Kmak D, Brenner DE, Ruffin MT. Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res 2004; 17:55 - 60; http://dx.doi.org/10.1016/j.apnr.2003.12.002; PMID: 14991556
   PubMed Web of Science ®Google Scholar
• Brown-Peterside P, Chiasson MA, Ren L, Koblin BA. Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City. J Urban Health 2000; 77:425 - 37; http://dx.doi.org/10.1007/BF02386751; PMID: 10976615
   PubMed Web of Science ®Google Scholar
• Dhalla S, Poole G, Singer J, Patrick DM, Kerr T. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-positive injection drug users. Psychol Health Med 2012; 17:223 - 34; http://dx.doi.org/10.1080/13548506.2011.608803; PMID: 22250925
   PubMed Web of Science ®Google Scholar
• Etcheverry MF, de Lazzari E, Fuchs JD, Meroño M, Sierra E, Del Romero J, et al. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain. AIDS Behav 2010; 14:607 - 17; http://dx.doi.org/10.1007/s10461-008-9486-x; PMID: 19037720
   PubMed Web of Science ®Google Scholar
• Celentano DD, Beyrer C, Natpratan C, Eiumtrakul S, Sussman L, Renzullo PO, et al. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand. AIDS 1995; 9:1079 - 83; http://dx.doi.org/10.1097/00002030-199509000-00015; PMID: 8527082
   PubMed Web of Science ®Google Scholar
• Koblin BA, Holte S, Lenderking B, Heagerty P, The HIVNET Vaccine Preparedness Study Protocol Team. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. J Acquir Immune Defic Syndr 2000; 24:451 - 7; PMID: 11035616
   PubMed Web of Science ®Google Scholar
• Etcheverry MF, Lum PJ, Evans JL, Sanchez E, de Lazzari E, Mendez-Arancibia E, et al. HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco. Vaccine 2011; 29:1991 - 6; http://dx.doi.org/10.1016/j.vaccine.2010.12.043; PMID: 21241735
   PubMed Web of Science ®Google Scholar
• Aliyu G, Mohammad M, Saidu A, Mondal P, Charurat M, Abimiku A, et al. HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria. AIDS Care 2010; 22:1277 - 84; http://dx.doi.org/10.1080/09540121003692219; PMID: 20661789
   PubMed Web of Science ®Google Scholar
• de Bruyn G, Hudgens MG, Sullivan PS, Duerr AC. Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr 2005; 39:499 - 501; http://dx.doi.org/10.1097/01.qai.0000148532.12329.df; PMID: 16010176
   PubMed Web of Science ®Google Scholar
• Golub ET, Purvis LA, Sapun M, Safaeian M, Beyrer C, Vlahov D, et al. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users. AIDS Behav 2005; 9:301 - 9; http://dx.doi.org/10.1007/s10461-005-9004-3; PMID: 16088366
   PubMed Web of Science ®Google Scholar
• Djomand G, Metch B, Zorrilla CD, Donastorg Y, Casapia M, Villafana T, et al, 903 Protocol Team. The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr 2008; 48:82 - 9; http://dx.doi.org/10.1097/QAI.0b013e31817236ab; PMID: 18391750
   PubMed Web of Science ®Google Scholar
• Jaspan HB, Flisher AJ, Myer L, Mathews C, Middelkoop K, Mark D, et al. Sexual health, HIV risk, and retention in an adolescent HIV-prevention trial preparatory cohort. J Adolesc Health 2011; 49:42 - 6; http://dx.doi.org/10.1016/j.jadohealth.2010.10.009; PMID: 21700155
   PubMed Web of Science ®Google Scholar
• Chauhan H, Lal P, Kumar V, Malhotra R, Ingle GK. Awareness status about HIV/AIDS among Indian railway’s employees and their family members. J Commun Dis 2008; 40:295 - 9; PMID: 19579724
   PubMedGoogle Scholar
• Sudha RT, Vijay DT, Lakshmi V. Awareness, attitudes, and beliefs of the general public towards HIV/AIDS in Hyderabad, a capital city from South India. Indian J Med Sci 2005; 59:307 - 16; http://dx.doi.org/10.4103/0019-5359.16506; PMID: 16062018
   PubMedGoogle Scholar
• Lindegger G, Quayle M, Ndlovu M. Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa. Health Educ Behav 2007; 34:108 - 23; http://dx.doi.org/10.1177/1090198105277852; PMID: 16740504
   PubMed Web of Science ®Google Scholar
• McGrath JW, George K, Svilar G, Ihler E, Mafigiri D, Kabugo M, et al. Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military. J Acquir Immune Defic Syndr 2001; 27:381 - 8; PMID: 11468427
   PubMed Web of Science ®Google Scholar
• Koblin BA, Heagerty P, Sheon A, Buchbinder S, Celum C, Douglas JM, et al. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS 1998; 12:785 - 93; http://dx.doi.org/10.1097/00002030-199807000-00015; PMID: 9619811
   PubMed Web of Science ®Google Scholar
• Suhadev M, Nyamathi AM, Swaminathan S, Venkatesan P, Raja Sakthivel M, Shenbagavalli R, et al. A pilot study on willingness to participate in future preventive HIV vaccine trials. Indian J Med Res 2006; 124:631 - 40; PMID: 17287550
   PubMed Web of Science ®Google Scholar
• Suhadev M, Nyamathi AM, Swaminathan S, Suresh A, Venkatesan P. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retroviruses 2009; 25:217 - 24; http://dx.doi.org/10.1089/aid.2007.0312; PMID: 19239362
   PubMed Web of Science ®Google Scholar
• Van de Ven P, Mao L, Crawford J, Prestage G, Grulich A, Kaldor J, et al. Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia. Int J STD AIDS 2005; 16:314 - 7; http://dx.doi.org/10.1258/0956462053654212; PMID: 15899086
   PubMed Web of Science ®Google Scholar
• Bartholow BN, MacQueen KM, Douglas JM Jr., Buchbinder S, McKirnan D, Judson FN. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:108 - 15; http://dx.doi.org/10.1097/00042560-199710010-00006; PMID: 9358105
   PubMedGoogle Scholar
• Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E. Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 2004; 36:604 - 12; http://dx.doi.org/10.1097/00126334-200405010-00009; PMID: 15097304
   PubMed Web of Science ®Google Scholar
• Pluhar E, McDonnell Holstad M, Yeager KA, Denzmore-Nwagbara P, Corkran C, Fielder B, et al. Implementation of audio computer-assisted interviewing software in HIV/AIDS research. J Assoc Nurses AIDS Care 2007; 18:51 - 63; http://dx.doi.org/10.1016/j.jana.2007.05.002; PMID: 17662924
   PubMed Web of Science ®Google Scholar
• Simoes AA, Bastos FI, Moreira RI, Lynch KG, Metzger DS. A randomized trial of audio computer and in-person interview to assess HIV risk among drug and alcohol users in Rio De Janeiro, Brazil. J Subst Abuse Treat 2006; 30:237 - 43; http://dx.doi.org/10.1016/j.jsat.2005.12.002; PMID: 16616168
   PubMed Web of Science ®Google Scholar